Drug Trial Radar · NCT05931276
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,540
Planned (sponsor's estimate)
Start
May 22, 2024
Primary completion
Dec 31, 2026
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- First posted
- Jul 5, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The investigators aim to determine, using a point-of-care randomized controlled trial design, if hemodialysis patients, who are randomized to metoprolol succinate (a dialyzable, beta-1 selective beta blocker), have an improved cardiovascular outcome compared to those randomized to carvedilol (a non-dialyzable, non-selective beta blocker with alpha-1 antagonist properties). The investigators will also examine intervention practices to identify components that best support engagement and sustainability.
Conditions
- End-Stage Kidney Disease
- End-Stage Renal Disease
Interventions
Metoprolol SuccinateDrug
a dialyzable, beta-1 selective beta blocker
CarvedilolDrug
a non-dialyzable, non-selective beta blocker with alpha-1 antagonist properties
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to major cardiovascular eventTime frame: Randomization to time to event; average follow-up 3 years
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California · Recruiting
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado · Recruiting
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut · Not yet recruiting
North Florida/South Georgia Veterans Health System, Gainesville, FL
Gainesville, Florida · Recruiting
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia · Not yet recruiting
Jesse Brown VA Medical Center, Chicago, IL
Chicago, Illinois · Recruiting
Iowa City VA Health Care System, Iowa City, IA
Iowa City, Iowa · Recruiting
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts · Not yet recruiting
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota · Recruiting
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Omaha, Nebraska · Recruiting
New Mexico VA Health Care System, Albuquerque, NM
Albuquerque, New Mexico · Recruiting
Durham VA Medical Center, Durham, NC
Durham, North Carolina · Recruiting
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
Salisbury, North Carolina · Not yet recruiting
Philadelphia MultiService Center, Philadelphia, PA
Philadelphia, Pennsylvania · Recruiting
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania · Recruiting
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Dallas, Texas · Not yet recruiting
VA Salt Lake City Health Care System, Salt Lake City, UT
Salt Lake City, Utah · Recruiting
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.